- Home
- NTHI vs OSUR Comparison
NTHI vs OSUR Comparison
Compare NTHI & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTHI
- OSUR
- Stock Information
- Founded
- NTHI 2008
- OSUR 2000
- Country
- NTHI United States
- OSUR United States
- Employees
- NTHI N/A
- OSUR N/A
- Industry
- NTHI Biotechnology: Pharmaceutical Preparations
- OSUR Medical/Dental Instruments
- Sector
- NTHI Health Care
- OSUR Health Care
- Exchange
- NTHI Nasdaq
- OSUR Nasdaq
- Market Cap
- NTHI 195.5M
- OSUR 177.2M
- IPO Year
- NTHI N/A
- OSUR 1986
- Fundamental
- Price
- NTHI $6.40
- OSUR $2.11
- Analyst Decision
- NTHI
- OSUR Hold
- Analyst Count
- NTHI 0
- OSUR 2
- Target Price
- NTHI N/A
- OSUR $3.00
- AVG Volume (30 Days)
- NTHI 62.7K
- OSUR 639.4K
- Earning Date
- NTHI 11-14-2025
- OSUR 11-05-2025
- Dividend Yield
- NTHI N/A
- OSUR N/A
- EPS Growth
- NTHI N/A
- OSUR N/A
- EPS
- NTHI N/A
- OSUR N/A
- Revenue
- NTHI $59,990.00
- OSUR $125,703,000.00
- Revenue This Year
- NTHI N/A
- OSUR N/A
- Revenue Next Year
- NTHI N/A
- OSUR $4.32
- P/E Ratio
- NTHI N/A
- OSUR N/A
- Revenue Growth
- NTHI N/A
- OSUR N/A
- 52 Week Low
- NTHI $3.20
- OSUR $2.10
- 52 Week High
- NTHI $25.00
- OSUR $4.22
- Technical
- Relative Strength Index (RSI)
- NTHI 31.38
- OSUR 26.37
- Support Level
- NTHI $8.93
- OSUR $2.20
- Resistance Level
- NTHI $9.57
- OSUR $2.35
- Average True Range (ATR)
- NTHI 1.15
- OSUR 0.13
- MACD
- NTHI -0.46
- OSUR -0.02
- Stochastic Oscillator
- NTHI 0.00
- OSUR 2.33
About NTHI NeOnc Technologies Holdings Inc. Common Stock
NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration (FDA).
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.